• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压与非酒精性脂肪性肝病之间的关联:一项横断面和荟萃分析研究。

Association between hypertension and nonalcoholic fatty liver disease: a cross-sectional and meta-analysis study.

作者信息

Huang Qingzhi, Yu Hana, Zhong Xin, Tian Ying, Cui Zhenhua, Quan Zhenyu

机构信息

Department of Preventive Medicine, Medical College, Yanbian University, 977 Gongyuan Street, Yanji, 133000, Jilin, China.

Department of Nephrology, Yanbian University Hospital, 119 Juzi Street, Yanji, 133000, Jilin, China.

出版信息

J Hum Hypertens. 2023 Apr;37(4):313-320. doi: 10.1038/s41371-022-00686-w. Epub 2022 Apr 11.

DOI:10.1038/s41371-022-00686-w
PMID:35411023
Abstract

The association between hypertension and nonalcoholic fatty liver disease (NAFLD) is not completely understood. This study aimed to investigate the association between hypertension and hepatic ultrasound examination-diagnosed positive NAFLD in healthy people; to conduct a comprehensive meta-analysis combining the results of previous studies; to explore whether hypertension was a risk factor for NAFLD. This study included 2049 adults (male: 870 and female: 1179), aged ≥20 years, whose anthropometric parameters were measured to analyze the risk of hypertension on NAFLD. We also collected data from 11 cross-sectional studies relevant to this topic using PubMed, Embase, Web of Science, CNKI, Wanfang, and CQVIP from beginning till 31 August 2020 and combined it with our data for a meta-analysis to explore whether hypertension was a risk factor for NAFLD. After adjusting for confounding factors, the odds of NAFLD in hypertensive subjects was 1.473 (95%CI: 1.119-1.938). After combining with 10 selected studies, 42711 participants were enrolled in meta-analysis. Hypertension was a risk factor for NAFLD (Z = 13.46, P < 0.001); the odds of NAFLD in hypertensive subjects was 1.43 (95%CI: 1.36-1.51). The results were consistent with the results of the meta-analysis. Further studies are required to confirm these results.

摘要

高血压与非酒精性脂肪性肝病(NAFLD)之间的关联尚未完全明确。本研究旨在调查健康人群中高血压与肝脏超声检查诊断为阳性的NAFLD之间的关联;对既往研究结果进行综合荟萃分析;探讨高血压是否为NAFLD的危险因素。本研究纳入了2049名年龄≥20岁的成年人(男性870名,女性1179名),测量其人体测量学参数以分析高血压对NAFLD的风险。我们还使用PubMed、Embase、Web of Science、中国知网、万方和维普,收集了从开始至2020年8月31日与该主题相关的11项横断面研究的数据,并将其与我们的数据合并进行荟萃分析,以探讨高血压是否为NAFLD的危险因素。在调整混杂因素后,高血压患者发生NAFLD的比值比为1.473(95%置信区间:1.119 - 1.938)。与10项选定研究合并后,有42711名参与者纳入荟萃分析。高血压是NAFLD的危险因素(Z = 13.46,P < 0.001);高血压患者发生NAFLD的比值比为1.43(95%置信区间:1.36 - 1.51)。结果与荟萃分析结果一致。需要进一步研究来证实这些结果。

相似文献

1
Association between hypertension and nonalcoholic fatty liver disease: a cross-sectional and meta-analysis study.高血压与非酒精性脂肪性肝病之间的关联:一项横断面和荟萃分析研究。
J Hum Hypertens. 2023 Apr;37(4):313-320. doi: 10.1038/s41371-022-00686-w. Epub 2022 Apr 11.
2
Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.年龄在 45-60 岁的中国人群中,非酒精性脂肪肝与高血压之间的相关性存在性别差异。
Clin Exp Hypertens. 2016;38(7):639-643. doi: 10.1080/10641963.2016.1182181. Epub 2016 Sep 28.
3
Diurnal rhythm of follicle-stimulating hormone is associated with nonalcoholic fatty liver disease in a Chinese elderly population.中国老年人群中促卵泡生成素的昼夜节律与非酒精性脂肪性肝病相关。
Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:166-170. doi: 10.1016/j.ejogrb.2018.01.034. Epub 2018 Jan 31.
4
Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.非酒精性脂肪肝疾病与弗雷明汉研究中健康中年成年人脑容量降低的关联。
JAMA Neurol. 2018 Jan 1;75(1):97-104. doi: 10.1001/jamaneurol.2017.3229.
5
Is Vitamin D an Independent Risk Factor of Nonalcoholic Fatty Liver Disease?: a Cross-Sectional Study of the Healthy Population.维生素D是非酒精性脂肪性肝病的独立危险因素吗?:一项健康人群的横断面研究。
J Korean Med Sci. 2017 Jan;32(1):95-101. doi: 10.3346/jkms.2017.32.1.95.
6
Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study.残余胆固醇与非酒精性脂肪性肝病的关联:一项基于一般人群的研究。
Lipids Health Dis. 2021 Oct 17;20(1):139. doi: 10.1186/s12944-021-01573-y.
7
Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: A cross-sectional study in Chongqing, China.非酒精性脂肪性肝病在健康成年人中的流行情况及相关危险因素:一项在中国重庆的横断面研究。
Front Public Health. 2023 Mar 30;11:1127489. doi: 10.3389/fpubh.2023.1127489. eCollection 2023.
8
Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.高尿酸血症与非酒精性脂肪性肝病风险:一项系统评价和荟萃分析。
Eur J Gastroenterol Hepatol. 2016 Feb;28(2):132-8. doi: 10.1097/MEG.0000000000000507.
9
Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.非酒精性脂肪肝与心血管代谢危险因素的关系:横断面研究。
Biol Sex Differ. 2022 Nov 4;13(1):64. doi: 10.1186/s13293-022-00475-7.
10
High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis.高血清尿酸与非酒精性脂肪性肝病风险:一项系统评价与荟萃分析
Clin Biochem. 2016 May;49(7-8):636-42. doi: 10.1016/j.clinbiochem.2015.12.010. Epub 2015 Dec 29.

引用本文的文献

1
Serum Osteopontin and Procollagen Type 1 N-Terminal Propeptide Concentrations: Links to Liver Function, Muscle Mass, and Bone Mineral Density in MASLD and Hypertension.血清骨桥蛋白和1型前胶原N端前肽浓度:与代谢相关脂肪性肝病和高血压患者肝功能、肌肉量及骨密度的关联
Metabolites. 2025 Jul 6;15(7):459. doi: 10.3390/metabo15070459.
2
The relationship between hepatic steatosis index and hypertension: NHANES 2011-2018.肝脏脂肪变性指数与高血压之间的关系:2011 - 2018年美国国家健康与营养检查调查(NHANES)
BMC Cardiovasc Disord. 2025 Apr 17;25(1):289. doi: 10.1186/s12872-025-04744-2.
3
The Predictive Value of Time-Varying Noninvasive Scores on Long-Term Prognosis of NAFLD in South Korea.

本文引用的文献

1
Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories.美国成年人中不同血压类别中非酒精性脂肪肝疾病和肝纤维化的进展。
Hypertension. 2020 Aug;76(2):562-568. doi: 10.1161/HYPERTENSIONAHA.120.15220. Epub 2020 Jun 29.
2
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
3
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease.
时间相关无创评分对韩国非酒精性脂肪性肝病长期预后的预测价值。
Can J Gastroenterol Hepatol. 2024 Sep 16;2024:5667986. doi: 10.1155/2024/5667986. eCollection 2024.
4
Evaluating the relative importance of different blood pressure indices in screening for NAFLD: a survey report based on a health examination population.评估不同血压指标在非酒精性脂肪性肝病筛查中的相对重要性:一项基于健康体检人群的调查报告
Front Cardiovasc Med. 2024 Apr 29;11:1338156. doi: 10.3389/fcvm.2024.1338156. eCollection 2024.
5
Identifying metabolic dysfunction-associated steatotic liver disease in patients with hypertension and pre-hypertension: An interpretable machine learning approach.识别高血压和高血压前期患者中与代谢功能障碍相关的脂肪性肝病:一种可解释的机器学习方法。
Digit Health. 2024 Feb 21;10:20552076241233135. doi: 10.1177/20552076241233135. eCollection 2024 Jan-Dec.
6
Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?非酒精性脂肪性肝病和动脉高血压,哪个先出现?
Biomedicines. 2023 Sep 5;11(9):2465. doi: 10.3390/biomedicines11092465.
7
Association between use of vitamin and mineral supplement and non-alcoholic fatty liver disease in hypertensive adults.补充维生素和矿物质与高血压成年人非酒精性脂肪性肝病的相关性。
Sci Rep. 2023 Aug 22;13(1):13670. doi: 10.1038/s41598-023-40868-1.
8
Association Between Hypertension and New-Onset Non-Alcoholic Fatty Liver Disease in Chinese Non-Obese People: A Longitudinal Cohort Study.中国非肥胖人群中高血压与新发非酒精性脂肪性肝病的关联:一项纵向队列研究
Diabetes Metab Syndr Obes. 2023 Feb 8;16:345-363. doi: 10.2147/DMSO.S396011. eCollection 2023.
代谢特征对非酒精性脂肪性肝病患者肝硬化和肝细胞癌风险的影响。
Hepatology. 2020 Mar;71(3):808-819. doi: 10.1002/hep.31014. Epub 2020 Feb 26.
4
Epidemiology of chronic liver diseases in the USA in the past three decades.美国过去三十年慢性肝脏疾病的流行病学。
Gut. 2020 Mar;69(3):564-568. doi: 10.1136/gutjnl-2019-318813. Epub 2019 Jul 31.
5
Nonalcoholic fatty liver disease represents a greater metabolic burden in patients with atherosclerosis: A cross-sectional study.非酒精性脂肪性肝病在动脉粥样硬化患者中代表着更大的代谢负担:一项横断面研究。
Medicine (Baltimore). 2019 Mar;98(11):e14896. doi: 10.1097/MD.0000000000014896.
6
Bidirectional association between nonalcoholic fatty liver disease and hypertension from the Dongfeng-Tongji cohort study.来自东风-同济队列研究的非酒精性脂肪性肝病与高血压之间的双向关联
J Am Soc Hypertens. 2018 Sep;12(9):660-670. doi: 10.1016/j.jash.2018.06.013. Epub 2018 Jul 3.
7
Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey.非酒精性脂肪性肝病的危险因素和生物标志物:一项观察性横断面人群调查。
BMJ Open. 2018 Apr 5;8(4):e019974. doi: 10.1136/bmjopen-2017-019974.
8
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?高血压、糖尿病、动脉粥样硬化和 NASH:病因还是后果?
J Hepatol. 2018 Feb;68(2):335-352. doi: 10.1016/j.jhep.2017.09.021. Epub 2017 Nov 6.
9
Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients.病态肥胖非酒精性脂肪性肝病患者肝纤维化进展的预测因素
World J Hepatol. 2017 Jan 18;9(2):91-98. doi: 10.4254/wjh.v9.i2.91.
10
Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies.肥胖症是导致非酒精性脂肪肝的一个独立风险因素:来自 21 项队列研究的荟萃分析证据。
Obes Rev. 2016 Jun;17(6):510-9. doi: 10.1111/obr.12407. Epub 2016 Mar 28.